Dylan Beynon, CEO of Mindbloom: How ketamine-assisted therapy treats anxiety and depression
Dylan Beynon, CEO of Mindbloom: How ketamine-assisted therapy treats anxiety and depression
Today’s episode features Dylan Beynon from Mindbloom, a mental and wellbeing startup that is currently offering ketamine... Read more
21 Jun 2020
•
31mins
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
Today’s episode features Shelby Hartman and Madison Margolin from DoubleBlind, a psychedelic magazine and media company ... Read more
13 Aug 2020
•
26mins
Similar Podcasts
Psychedelics Today
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
Today's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psyc... Read more
17 Sep 2020
•
57mins
Helping psychedelic practitioners through software: Maya Health CEO David Champion
Helping psychedelic practitioners through software: Maya Health CEO David Champion
Today's episode features David Champion, CEO and co-founder of Maya, a software platform that helps practitioners and cl... Read more
19 Oct 2020
•
29mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
From serving medicine to company founder: NANA founder Flor Bollini
From serving medicine to company founder: NANA founder Flor Bollini
Today's episode features Flor Bollini, founder of NANA, an online platform that guides patients on using psychedelic med... Read more
5 Jan 2021
•
33mins
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
Today's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, ... Read more
24 Feb 2021
•
30mins
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
Today's episode features Zach Haigney, creator of The Trip Report, a newsletter about psychedelics, policy and business.... Read more
16 Mar 2021
•
21mins
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Today's episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies... Read more
4 May 2021
•
44mins
Analyzing the atai Life Sciences IPO
Analyzing the atai Life Sciences IPO
Today's episode features three experts, Josh Hardman, Michael Haichin, and Graham Pechenik as they analyze atai’s S-1 in... Read more
10 Jun 2021
•
50mins
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with ... Read more
13 Aug 2021
•
59mins
